Drug Profile
Doxapram
Alternative Names: DopramLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Unknown
- Developer Kissei Pharmaceutical; Unknown
- Class Morpholines; Pyrrolidinones; Respiratory stimulants; Small molecules
- Mechanism of Action Central nervous system stimulants; Chemoreceptor cell stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Apnoea; Respiratory insufficiency